Piramal Healthcare has received approval from the Drug Controller General of India to conduct Phase-II clinical trials of the cancer drug, P276, in combination with chemoradiation for head and neck Read More
Piramal Healthcare Gets Green Signal for Phase II Trials of Cancer Drug
